Margarita N. Sinkova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Margarita N. Sinkova has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Leonid K. Isakov
Kemerovo State Medical University
12 shared publications - Ekaterina Yu. Plotnikova
Kemerovo State Medical University
8 shared publications - Ol'Ga Leonidovna Barbarash
Federal State Budgetary Scientific Institution “Research Institute for Complex Issues of Cardiovascular Diseases”, Academician L.S. Barbarash Boulevard, 6, Kemerovo 650002, Russia
7 shared publications - Nikolay I. Tarasov
Federal State Budgetary Educational Institution of Higher Education “Kemerovo State Medical University” of the Ministry of Health of the Russian Federation
4 shared publications - Alexander T. Teplyakov
Cardiology Research Institute, Tomsk National Research Medical Center (NRMC), Russian Academy of Sciences
3 shared publications - Elena V. Grakova
Cardiology Research Institute, Tomsk National Research Medical Center (NRMC), Russian Academy of Sciences
2 shared publications
Latest Publications
- Open Access
- 4 May 2026
- Published by NII KPSSZ in Complex Issues of Cardiovascular Diseases
- Vol. 15 (2) , 6-16
PREVALENCE AND CLINICAL SIGNIFICANCE OF IRON DEICIENCY IN PATIENTS WITH ACUTE DECOMPENSATED HEART FAILURE: RESULTS OF A SINGLE-CENTER COHORT STUDY
Highlights Iron deficiency is one of the most common comorbidities in heart failure, associated with a negative prognosis; however, the significance of iron deficiency in patients with acute decompensated heart failure remains uncertain. The obtained results allowed us to expand the profile of patients with acute decompensated heart failure and evaluate the contribution of iron deficiency to the course of the disease and the long-term prognosis of patients. Aim . To determine the prevalence of iron deficiency (ID), to assess its clinical and prognostic significance, and its impact on one-year outcomes in patients with acute decompensated heart failure, based on data from a single-center cohort study. Methods. This prospective cohort study consecutively (from January 1, 2023 to January 1, 2024) included 812 patients admitted with acute decompensated heart failure. The observation period was from January 1, 2023 to January 1, 2025, inclusive. The median age was 72 [57; 83] years. Results. The clinical phenotypes of patients with ADHF were predominantly represented by an ischemic origin of heart failure. All patients with ADHF had a high prevalence of hypertension and a high Charlson comorbidity index. It was found that patients with ID had significantly higher NT-proBNP values than patients without ID: 2810.8 [1 783.6; 4 198.3] versus 1 981.2 [1 221.5; 3 241.7] pg/ml. Patients with ID had a higher prevalence of major underlying diseases: type 2 diabetes (n = 181, 37.0% vs n = 102, 31.5%; p < 0.05), obesity (n = 378, 77.3% vs n = 170, 52.6%, p < 0.05), CKD (n = 263, 53.9% vs n = 144, 44.5%, p < 0.05); as well as older age (76 [54; 83] vs 69 [47; 79] years). The total number of adverse events was higher in the group of patients with ID. Conclusions. The prevalence of iron deficiency in patients with ADHF was 60%. Patients with ID were characterized by older age, a high prevalence of type 2 diabetes, obesity, and CKD, as well as a greater number of adverse events during the long-term follow-up period.
- 4 May 2026
- Published by NII KPSSZ in Complex Issues of Cardiovascular Diseases
- Vol. 15 (2) , 6-16
Open AccessPREVALENCE AND CLINICAL SIGNIFICANCE OF IRON DEICIENCY IN PATIENTS WITH ACUTE DECOMPENSATED HEART FAILURE: RESULTS OF A SINGLE-CENTER COHORT STUDY
Highlights Iron deficiency is one of the most common comorbidities in heart failure, associated with a negative prognosis; however, the significance of iron deficiency in patients with acute decompensated heart failure remains uncertain. The obtained results allowed us to expand the profile of patients with acute decompensated heart failure and evaluate the contribution of iron deficiency to the course of the disease and the long-term prognosis of patients. Aim . To determine the prevalence of iron deficiency (ID), to assess its clinical and prognostic significance, and its impact on one-year outcomes in patients with acute decompensated heart failure, based on data from a single-center cohort study. Methods. This prospective cohort study consecutively (from January 1, 2023 to January 1, 2024) included 812 patients admitted with acute decompensated heart failure. The observation period was from January 1, 2023 to January 1, 2025, inclusive. The median age was 72 [57; 83] years. Results. The clinical phenotypes of patients with ADHF were predominantly represented by an ischemic origin of heart failure. All patients with ADHF had a high prevalence of hypertension and a high Charlson comorbidity index. It was found that patients with ID had significantly higher NT-proBNP values than patients without ID: 2810.8 [1 783.6; 4 198.3] versus 1 981.2 [1 221.5; 3 241.7] pg/ml. Patients with ID had a higher prevalence of major underlying diseases: type 2 diabetes (n = 181, 37.0% vs n = 102, 31.5%; p < 0.05), obesity (n = 378, 77.3% vs n = 170, 52.6%, p < 0.05), CKD (n = 263, 53.9% vs n = 144, 44.5%, p < 0.05); as well as older age (76 [54; 83] vs 69 [47; 79] years). The total number of adverse events was higher in the group of patients with ID. Conclusions. The prevalence of iron deficiency in patients with ADHF was 60%. Patients with ID were characterized by older age, a high prevalence of type 2 diabetes, obesity, and CKD, as well as a greater number of adverse events during the long-term follow-up period.
- 30 December 2025
- Published by NII KPSSZ in Complex Issues of Cardiovascular Diseases
- Vol. 14 (6S)
EFFECTIVENESS OF TELEPHONE MONITORING OF PATIENTS WITH CHRONIC HEART FAILURE BY NURSES
Highlights The management of patients with chronic heart failure (CHF), with its high mortality and hospitalization rates, is a pressing issue. Active patient monitoring through telephone visits conducted by medical personnel has proven effective in managing the risk of adverse events in this patient population. Aim . To evaluate the effectiveness of remote patronage by nurses (brothers) of patients with CHF using telephone “visits”. Methods . 108 patients were included: group 1 – active control using telephone “visits”, group 2 – traditional follow-up. Telephone “visits” were conducted weekly for 1 month after inclusion in the study, then once a month for the next 5 months. After 1 year, the patient's status was assessed: “alive/dead”, the number of requests for medical help due to decompensation of heart failure. Results . During the 6 months of follow–up, the following were registered: in the active control group – 10 emergency medical team calls, 5 hospitalizations, 25 outpatient visits to a cardiologist, there were no deaths; in the traditional follow-up group – 18 NSR team calls, 16 hospitalizations, 29 outpatient visits to a cardiologist. The proportion of patients taking 4-component therapy increased: in the active control group – up to 74.1%, in the traditional follow–up group – up to 22.2% (p < 0.0001). The proportion of patients taking 3 or more drugs in the active control group was more than 90%, in the traditional follow–up group – 46.3% (p < 0.0001). After 1 year, there were 3 deaths in the active control group and 5 deaths in the traditional follow–up group. Calls to the NSR team were 12 and 17, episodes of hospitalization were 10 and 19, outpatient visits to a cardiologist were 13 and 19 (in the active control and traditional follow–up group, respectively). A decrease in the proportion of patients taking 4-component therapy: in the active control group – from 74.1% to 27.8%, in the traditional follow-up group – from 29.6% to 16.7%. Conclusion . Telephone “visits” have a high potential in managing the risks of adverse events in patients with CHF.
- 30 December 2025
- Published by NII KPSSZ in Complex Issues of Cardiovascular Diseases
- Vol. 14 (6S)
EFFECTIVENESS OF TELEPHONE MONITORING OF PATIENTS WITH CHRONIC HEART FAILURE BY NURSES
Highlights The management of patients with chronic heart failure (CHF), with its high mortality and hospitalization rates, is a pressing issue. Active patient monitoring through telephone visits conducted by medical personnel has proven effective in managing the risk of adverse events in this patient population. Aim . To evaluate the effectiveness of remote patronage by nurses (brothers) of patients with CHF using telephone “visits”. Methods . 108 patients were included: group 1 – active control using telephone “visits”, group 2 – traditional follow-up. Telephone “visits” were conducted weekly for 1 month after inclusion in the study, then once a month for the next 5 months. After 1 year, the patient's status was assessed: “alive/dead”, the number of requests for medical help due to decompensation of heart failure. Results . During the 6 months of follow–up, the following were registered: in the active control group – 10 emergency medical team calls, 5 hospitalizations, 25 outpatient visits to a cardiologist, there were no deaths; in the traditional follow-up group – 18 NSR team calls, 16 hospitalizations, 29 outpatient visits to a cardiologist. The proportion of patients taking 4-component therapy increased: in the active control group – up to 74.1%, in the traditional follow–up group – up to 22.2% (p < 0.0001). The proportion of patients taking 3 or more drugs in the active control group was more than 90%, in the traditional follow–up group – 46.3% (p < 0.0001). After 1 year, there were 3 deaths in the active control group and 5 deaths in the traditional follow–up group. Calls to the NSR team were 12 and 17, episodes of hospitalization were 10 and 19, outpatient visits to a cardiologist were 13 and 19 (in the active control and traditional follow–up group, respectively). A decrease in the proportion of patients taking 4-component therapy: in the active control group – from 74.1% to 27.8%, in the traditional follow-up group – from 29.6% to 16.7%. Conclusion . Telephone “visits” have a high potential in managing the risks of adverse events in patients with CHF.
- 30 December 2025
- Published by NII KPSSZ in Complex Issues of Cardiovascular Diseases
- Vol. 14 (6)
ACUTE HEART FAILURE AND DECOMPENSATED HEART FAILURE: THE IMPORTANCE OF MULTIMORBIDITY (LITERATURE REVIEW)
Highlights Understanding the interaction between various diseases in patients with acute heart failure and acute decompensated heart failure is key to developing effective prevention and management strategies aimed at improving the quality of medical care and reducing morbidity and mortality among this group of patients. Abstract Acute decompensated heart failure (ADHF) is a serious clinical condition that is often accompanied by multimorbidity, i.e. the presence of several chronic diseases simultaneously. These comorbidities significantly complicate the diagnosis, treatment and prognosis of outcomes in patients with ADHF. The review considers the most common comorbid conditions, such as arterial hypertension, diabetes mellitus, chronic kidney disease, obesity, depression and cognitive impairment. Each of these factors individually, as well as together (synergistically), affects the course of ADHF, increasing the risk of complications and worsening the patient's quality of life. Emphasizes the importance of an integrated approach to the management of patients with ADHF and multimorbidity. Early detection and pathogenetic therapy of comorbidities can reduce the frequency of hospitalizations, improve the functional capabilities of patients and increase life expectancy. Thus, understanding the interactions between various diseases in patients with ADHF is key to developing effective prevention and treatment strategies aimed at improving the quality of medical care and reducing morbidity and mortality in this group of patients.
- 30 December 2025
- Published by NII KPSSZ in Complex Issues of Cardiovascular Diseases
- Vol. 14 (6)
ACUTE HEART FAILURE AND DECOMPENSATED HEART FAILURE: THE IMPORTANCE OF MULTIMORBIDITY (LITERATURE REVIEW)
Highlights Understanding the interaction between various diseases in patients with acute heart failure and acute decompensated heart failure is key to developing effective prevention and management strategies aimed at improving the quality of medical care and reducing morbidity and mortality among this group of patients. Abstract Acute decompensated heart failure (ADHF) is a serious clinical condition that is often accompanied by multimorbidity, i.e. the presence of several chronic diseases simultaneously. These comorbidities significantly complicate the diagnosis, treatment and prognosis of outcomes in patients with ADHF. The review considers the most common comorbid conditions, such as arterial hypertension, diabetes mellitus, chronic kidney disease, obesity, depression and cognitive impairment. Each of these factors individually, as well as together (synergistically), affects the course of ADHF, increasing the risk of complications and worsening the patient's quality of life. Emphasizes the importance of an integrated approach to the management of patients with ADHF and multimorbidity. Early detection and pathogenetic therapy of comorbidities can reduce the frequency of hospitalizations, improve the functional capabilities of patients and increase life expectancy. Thus, understanding the interactions between various diseases in patients with ADHF is key to developing effective prevention and treatment strategies aimed at improving the quality of medical care and reducing morbidity and mortality in this group of patients.
- Open Access
- 29 September 2025
- Published by Kemerovo State Medical University in Fundamental and Clinical Medicine
- Vol. 10 (3) , 61-71
Mobile application as a tool for outpatient rehabilitation: experience and outcomes in patients after coronary artery bypass graft surgery
Aim. To assess the effectiveness and safety of remote monitoring of physical rehabilitation using a mobile application in patients after coronary artery bypass graft (CABG) surgery in comparison with the traditional model of outpatient cardiac rehabilitation. Materials and Methods. A total of 150 patients undergoing outpatient rehabilitation after CABG surgery were included in the study. Patients were randomized into three groups: 1) those underwent rehabilitation using a mobile application; 2) those who used pedometers for home-based monitoring of physical activity; 3) those who received standard rehabilitation under the supervision of a healthcare provider at their place of residence. The effectiveness and safety of supervised training were assessed during follow-up clinic visits at 4 and 12 months after CABG surgery by determining clinical and functional indicators, including physical activity levels, quality of life, and the frequency and severity of complications. Results. Remote monitoring of outpatient cardiac rehabilitation, conducted at home using a smartphone-based mobile application, and pedometers to dose physical activity without the mobile application demonstrated safety, as confirmed by the absence of destabilization episodes. The use of the mobile application for outpatient rehabilitation monitoring showed comparable effectiveness to the pedometer-based program in achieving target blood pressure levels within one year after CABG surgery (96% and 89%, respectively, compared with 49% without monitoring; p = 0.03). Only the mobile application group demonstrated a significant reduction in resting heart rate (from 71 [CI 64–76] to 65 [CI 62–70] beats per minute). All outpatient rehabilitation programs, whether remotely monitored or not, proved ineffective in achieving target lipid profile values. Conclusion. Remote monitoring in cardiac rehabilitation contributes to improved blood pressure control, reduced heart rate, and increased exercise tolerance within one year after CABG surgery.
- 29 September 2025
- Published by Kemerovo State Medical University in Fundamental and Clinical Medicine
- Vol. 10 (3) , 61-71
Open AccessMobile application as a tool for outpatient rehabilitation: experience and outcomes in patients after coronary artery bypass graft surgery
Aim. To assess the effectiveness and safety of remote monitoring of physical rehabilitation using a mobile application in patients after coronary artery bypass graft (CABG) surgery in comparison with the traditional model of outpatient cardiac rehabilitation. Materials and Methods. A total of 150 patients undergoing outpatient rehabilitation after CABG surgery were included in the study. Patients were randomized into three groups: 1) those underwent rehabilitation using a mobile application; 2) those who used pedometers for home-based monitoring of physical activity; 3) those who received standard rehabilitation under the supervision of a healthcare provider at their place of residence. The effectiveness and safety of supervised training were assessed during follow-up clinic visits at 4 and 12 months after CABG surgery by determining clinical and functional indicators, including physical activity levels, quality of life, and the frequency and severity of complications. Results. Remote monitoring of outpatient cardiac rehabilitation, conducted at home using a smartphone-based mobile application, and pedometers to dose physical activity without the mobile application demonstrated safety, as confirmed by the absence of destabilization episodes. The use of the mobile application for outpatient rehabilitation monitoring showed comparable effectiveness to the pedometer-based program in achieving target blood pressure levels within one year after CABG surgery (96% and 89%, respectively, compared with 49% without monitoring; p = 0.03). Only the mobile application group demonstrated a significant reduction in resting heart rate (from 71 [CI 64–76] to 65 [CI 62–70] beats per minute). All outpatient rehabilitation programs, whether remotely monitored or not, proved ineffective in achieving target lipid profile values. Conclusion. Remote monitoring in cardiac rehabilitation contributes to improved blood pressure control, reduced heart rate, and increased exercise tolerance within one year after CABG surgery.
- Open Access
- 1 January 2025
- Published by NP Rusmedical Group in Doctor.Ru
Efficiency and Safety of Remote Monitoring in Outpatient Cardiological Rehabilitation
Aim. To present effective strategies and recommendations for the creation and implementation of remotely monitored cardiac rehabilitation programs targeting different categories of patients with the aim of increasing overall adherence and reduce the risks of adverse outcomes. Key points. The effectiveness and safety of remotely controlled ambulatory cardiac rehabilitation are becoming important aspects of modern healthcare. Despite a compelling evidence base demonstrating the efficacy of traditional cardiac rehabilitation programs, their accessibility remains limited even in developed countries. In Russia, there is low patient engagement in such programs, which highlights the need for innovative solutions and personalized approaches during the outpatient stage of treatment. The widespread adoption of telemedicine technologies opens up new opportunities for introducing remote cardiac rehabilitation programs, including those utilizing mobile applications for monitoring the effectiveness and safety of recovery measures. The use of mobile apps allows physicians to track patients' conditions outside hospitals, ensuring an individualized approach and adapting programs to each patient's needs, as well as improving access to the third phase of cardiac rehabilitation. This review presents a summary of Russian and international research experience, along with our own efforts in implementing remote cardiac rehabilitation programs into practice. It emphasizes the importance of personalizing programs based on social, economic, and cultural characteristics of patients, as well as age, gender, place of residence, life style, and digital literacy. Such individualization contributes to increased patient adherence to prescribed recommendations and enhances the overall effectiveness of the programs. Special attention is given to the influence of social environment and personal motivation on the success of cardiac rehabilitation programs. A proposal is made for developing specialized approaches for each group of patients based on the results of analyzing demographic characteristics and levels of digital interaction. Conclusion. The development and implementation of remotely monitored cardiac rehabilitation programs improves improve the quality of care for patients with cardiovascular disease by increasing the accessibility and effectiveness of the rehabilitation process. Keywords: cardiac rehabilitation, telemedicine, smartphone applications, secondary prevention, patient commitment, patient engagement in cardiac rehabilitation programs
- 1 January 2025
- Published by NP Rusmedical Group in Doctor.Ru
Open AccessEfficiency and Safety of Remote Monitoring in Outpatient Cardiological Rehabilitation
Aim. To present effective strategies and recommendations for the creation and implementation of remotely monitored cardiac rehabilitation programs targeting different categories of patients with the aim of increasing overall adherence and reduce the risks of adverse outcomes. Key points. The effectiveness and safety of remotely controlled ambulatory cardiac rehabilitation are becoming important aspects of modern healthcare. Despite a compelling evidence base demonstrating the efficacy of traditional cardiac rehabilitation programs, their accessibility remains limited even in developed countries. In Russia, there is low patient engagement in such programs, which highlights the need for innovative solutions and personalized approaches during the outpatient stage of treatment. The widespread adoption of telemedicine technologies opens up new opportunities for introducing remote cardiac rehabilitation programs, including those utilizing mobile applications for monitoring the effectiveness and safety of recovery measures. The use of mobile apps allows physicians to track patients' conditions outside hospitals, ensuring an individualized approach and adapting programs to each patient's needs, as well as improving access to the third phase of cardiac rehabilitation. This review presents a summary of Russian and international research experience, along with our own efforts in implementing remote cardiac rehabilitation programs into practice. It emphasizes the importance of personalizing programs based on social, economic, and cultural characteristics of patients, as well as age, gender, place of residence, life style, and digital literacy. Such individualization contributes to increased patient adherence to prescribed recommendations and enhances the overall effectiveness of the programs. Special attention is given to the influence of social environment and personal motivation on the success of cardiac rehabilitation programs. A proposal is made for developing specialized approaches for each group of patients based on the results of analyzing demographic characteristics and levels of digital interaction. Conclusion. The development and implementation of remotely monitored cardiac rehabilitation programs improves improve the quality of care for patients with cardiovascular disease by increasing the accessibility and effectiveness of the rehabilitation process. Keywords: cardiac rehabilitation, telemedicine, smartphone applications, secondary prevention, patient commitment, patient engagement in cardiac rehabilitation programs
- Open Access
- 30 October 2024
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 16,p. 101-107
Role of physical training in cardiac rehabilitation in patients with congestive heart failure and type 2 diabetes mellitus
Introduction. Currently, the effectiveness of cardiac rehabilitation of patients with comorbid CHF using physical training when prescribing optimal drug therapy, including SGLT2 drugs, has not been studied.Aims. To study the effect of controlled physical training on the quality of life and prognosis of patients with CHF comorbid with type 2 diabetes mellitus against the background of rational pharmacotherapy.Materials and methods. The study included 74 patients with CHF against the background of type 2 diabetes mellitus, receiving optimal drug therapy, with mandatory intake of SGLT2 drugs. Two groups were formed using the simple randomization method: “Physical training” (n = 35) – basic drug therapy supplemented by a program of controlled physical training and “Standard drug therapy” (n = 37) – only basic drug therapy. Patients in the standard drug therapy group were recommended regular aerobic physical activity of moderate intensity for 30–60 minutes at least 5 days a week.Results. In the Physical Training group, after 12 months, an increase in the distance according to the results of the 6-minute walk test by 39.6% (on average 407.2 meters) was registered, in the Standard Drug Therapy group, physical tolerance increased by 12.2% (324.5 meters) (p = 0.002). According MLHFQ questionnaire in patients with CHF, the results were obtained that characterize the high social adaptation of patients during physical training in comparison with standard pathogenetic drug therapy. Thus, the MLHFQ indicator in the Physical Training group changed by an average of 25.2 points, and in the Standard Drug Therapy group – by 5.7 points, amounting to 37.3 ± 5.9 in the Physical Training group, and 58.2 ± 2.1 in the Standard Drug Therapy group (p = 0.001).Conclusions. Physical training in patients with CHF associated with type 2 diabetes mellitus against the background of optimal drug therapy leads to an increase in the distance according to the results of the 6-minute walk test and contributes to an improvement in the quality of life.
- 30 October 2024
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 16,p. 101-107
Open AccessRole of physical training in cardiac rehabilitation in patients with congestive heart failure and type 2 diabetes mellitus
Introduction. Currently, the effectiveness of cardiac rehabilitation of patients with comorbid CHF using physical training when prescribing optimal drug therapy, including SGLT2 drugs, has not been studied.Aims. To study the effect of controlled physical training on the quality of life and prognosis of patients with CHF comorbid with type 2 diabetes mellitus against the background of rational pharmacotherapy.Materials and methods. The study included 74 patients with CHF against the background of type 2 diabetes mellitus, receiving optimal drug therapy, with mandatory intake of SGLT2 drugs. Two groups were formed using the simple randomization method: “Physical training” (n = 35) – basic drug therapy supplemented by a program of controlled physical training and “Standard drug therapy” (n = 37) – only basic drug therapy. Patients in the standard drug therapy group were recommended regular aerobic physical activity of moderate intensity for 30–60 minutes at least 5 days a week.Results. In the Physical Training group, after 12 months, an increase in the distance according to the results of the 6-minute walk test by 39.6% (on average 407.2 meters) was registered, in the Standard Drug Therapy group, physical tolerance increased by 12.2% (324.5 meters) (p = 0.002). According MLHFQ questionnaire in patients with CHF, the results were obtained that characterize the high social adaptation of patients during physical training in comparison with standard pathogenetic drug therapy. Thus, the MLHFQ indicator in the Physical Training group changed by an average of 25.2 points, and in the Standard Drug Therapy group – by 5.7 points, amounting to 37.3 ± 5.9 in the Physical Training group, and 58.2 ± 2.1 in the Standard Drug Therapy group (p = 0.001).Conclusions. Physical training in patients with CHF associated with type 2 diabetes mellitus against the background of optimal drug therapy leads to an increase in the distance according to the results of the 6-minute walk test and contributes to an improvement in the quality of life.
- Open Access
- 27 September 2024
- Published by Kemerovo State Medical University in Fundamental and Clinical Medicine
- Vol. 9 (3) , 47-56
Impact of controlled physical training on clinicopathological and psychophysiological features of patients with chronic heart failure and type 2 diabetes
Aim. To evaluate the effectiveness of long-term (five-year) supervised physical exercise in patients with chronic heart failure (CHF) following myocardial infarction (MI) and type 2 diabetes mellitus (T2DM).Materials and Methods. The study included 88 patients with CHF of functional class II-III after MI and concomitant T2DM. In addition to standard medication therapy, patients in the main group (n = 42) performed regular moderate-intensity physical exercises for 30−60 minutes at least 5 days a week. The control group consisted of 46 patients who received standard medication therapy. Patients in both groups had similar clinical and demographic characteristics. After 5 years of follow-up, we assessed the incidence of a composite endpoint (death, MI, emergency myocardial revascularization, acute CHF decompensation), quality of life (measured by the SF36 questionnaire), levels of anxiety and depression (measured by the HADS questionnaire), and levels of fatigue (measured by the MFI-20 questionnaire). By the end of the five-year observation period, data were available for 40 patients in the main group (11 patients were excluded from the study due to discontinuation of regular physical exercise) and 42 patients in the control group.Results. The incidence of the composite endpoint was 55.2% and 80.9% in main and control group, respectively (p = 0.038). Regular physical exercise over the five-year period was associated with a higher quality of life according to the SF36 questionnaire (64.5 [63.1; 67.8] vs. 49.2 [48.4; 49.8], p = 0.001), lower levels of anxiety (5.8 [5.1; 7.7] vs. 8.0 [6.8; 9.2], p = 0.042) and depression (2.9 [2.2; 4.2] vs. 10.7 [10.5; 12.3], p = 0.001) according to the HADS questionnaire, and lower levels of general fatigue according to the MFI-20 questionnaire (9.1 [8.5; 11.2] vs. 15.1 [14.5; 15.4], p = 0.019).Conclusion. Long-term regular physical exercise in patients with CHF and T2DM improves cardiovascular outcomes and psychological status of patients.
- 27 September 2024
- Published by Kemerovo State Medical University in Fundamental and Clinical Medicine
- Vol. 9 (3) , 47-56
Open AccessImpact of controlled physical training on clinicopathological and psychophysiological features of patients with chronic heart failure and type 2 diabetes
Aim. To evaluate the effectiveness of long-term (five-year) supervised physical exercise in patients with chronic heart failure (CHF) following myocardial infarction (MI) and type 2 diabetes mellitus (T2DM).Materials and Methods. The study included 88 patients with CHF of functional class II-III after MI and concomitant T2DM. In addition to standard medication therapy, patients in the main group (n = 42) performed regular moderate-intensity physical exercises for 30−60 minutes at least 5 days a week. The control group consisted of 46 patients who received standard medication therapy. Patients in both groups had similar clinical and demographic characteristics. After 5 years of follow-up, we assessed the incidence of a composite endpoint (death, MI, emergency myocardial revascularization, acute CHF decompensation), quality of life (measured by the SF36 questionnaire), levels of anxiety and depression (measured by the HADS questionnaire), and levels of fatigue (measured by the MFI-20 questionnaire). By the end of the five-year observation period, data were available for 40 patients in the main group (11 patients were excluded from the study due to discontinuation of regular physical exercise) and 42 patients in the control group.Results. The incidence of the composite endpoint was 55.2% and 80.9% in main and control group, respectively (p = 0.038). Regular physical exercise over the five-year period was associated with a higher quality of life according to the SF36 questionnaire (64.5 [63.1; 67.8] vs. 49.2 [48.4; 49.8], p = 0.001), lower levels of anxiety (5.8 [5.1; 7.7] vs. 8.0 [6.8; 9.2], p = 0.042) and depression (2.9 [2.2; 4.2] vs. 10.7 [10.5; 12.3], p = 0.001) according to the HADS questionnaire, and lower levels of general fatigue according to the MFI-20 questionnaire (9.1 [8.5; 11.2] vs. 15.1 [14.5; 15.4], p = 0.019).Conclusion. Long-term regular physical exercise in patients with CHF and T2DM improves cardiovascular outcomes and psychological status of patients.
- Open Access
- 9 June 2024
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 8,p. 76-80
“Dark and bright sides” of Gilbert’s syndrome
Gilbert’s syndrome, also known as benign hyperbilirubinemia, was described more than 100 years ago. It has usually been considered a physiological abnormality characterized by a mild elevation of the systemic level of unconjugated bilirubin, in the absence of any underlying liver or overt RBC hemolysis. The molecular basis of Gilbert’s syndrome lies in the impairment of the conjugation of bilirubin with glucuronic acid in the hepatocytes, which is mediated by a specific hepatic enzyme named bilirubin-UDP-glucuronosyl transferase 1A1 that forms bilirubin diglucuronoside. Clearance of various xenobiotics, which are not substrates for glucuronosylation, is impaired in patients with Gilbert’s syndrome; their detailed list is provided in the article. Fatigue, asthenia, and various vaguely defined dyspeptic complaints attributed to Gilbert’s syndrome in the past are no longer considered a part of this condition, and proper evaluation of possible causes is required in these cases. Since the re-discovery of the potent antioxidant effects of bilirubin in the late 1980s, as well as the multiple intracellular signalling pathways affected by bilirubin, an ever-increasing body of evidence suggests that individuals with Gilbert’s syndrome may benefit from the mild hyperbilirubinemia and are actually protected from the development of a wide range of “diseases of civilization”, such as cardiovascular diseases, certain cancers, and autoimmune or neurodegenerative diseases. Gilbert’s syndrome is defined phenotypically, and therefore not according to predisposing genetic markers, as the elevation of serum unconjugated bilirubin concentration above the upper limit of normal, with no laboratory signs of hemolysis or liver damage. This review analyses the current state of medical knowledge given recent discoveries in this rapidly developing field, as well as their possible clinical significance, and provides a new perspective on this condition.
- 9 June 2024
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 8,p. 76-80
Open Access“Dark and bright sides” of Gilbert’s syndrome
Gilbert’s syndrome, also known as benign hyperbilirubinemia, was described more than 100 years ago. It has usually been considered a physiological abnormality characterized by a mild elevation of the systemic level of unconjugated bilirubin, in the absence of any underlying liver or overt RBC hemolysis. The molecular basis of Gilbert’s syndrome lies in the impairment of the conjugation of bilirubin with glucuronic acid in the hepatocytes, which is mediated by a specific hepatic enzyme named bilirubin-UDP-glucuronosyl transferase 1A1 that forms bilirubin diglucuronoside. Clearance of various xenobiotics, which are not substrates for glucuronosylation, is impaired in patients with Gilbert’s syndrome; their detailed list is provided in the article. Fatigue, asthenia, and various vaguely defined dyspeptic complaints attributed to Gilbert’s syndrome in the past are no longer considered a part of this condition, and proper evaluation of possible causes is required in these cases. Since the re-discovery of the potent antioxidant effects of bilirubin in the late 1980s, as well as the multiple intracellular signalling pathways affected by bilirubin, an ever-increasing body of evidence suggests that individuals with Gilbert’s syndrome may benefit from the mild hyperbilirubinemia and are actually protected from the development of a wide range of “diseases of civilization”, such as cardiovascular diseases, certain cancers, and autoimmune or neurodegenerative diseases. Gilbert’s syndrome is defined phenotypically, and therefore not according to predisposing genetic markers, as the elevation of serum unconjugated bilirubin concentration above the upper limit of normal, with no laboratory signs of hemolysis or liver damage. This review analyses the current state of medical knowledge given recent discoveries in this rapidly developing field, as well as their possible clinical significance, and provides a new perspective on this condition.
- Open Access
- 25 June 2023
- Published by NII KPSSZ in Complex Issues of Cardiovascular Diseases
- Vol. 12 (2) , 35-45
CLINICAL AND PROGNOSTIC FEATURES OF ELDERLY PATIENTS WITH UNSTABLE ANGINA PECTORIS UNDERGOING CONSERVATIVE TREATMENT DEPENDING ON LEFT VENTRICULAR EJECTION FRACTION
Highlights High cardiovascular morbidity and mortality in the Russian Federation and in Kuzbass is mainly due to high number of elderly and senile patients; it simply reflects the current demographic situation in the country. Elderly and senile patients with acute coronary syndrome (ACS) account for 50% of hospitalized patients. In real clinical practice, a significant number of elderly patients with ACS receive conservative treatment, whereas the prognosis in this cohort is determined by the development of recurrent coronary events and the progression of heart failure. Due to small number of patients older than 75-80 years included in randomized clinical trials, there are certain gaps in the management of elderly patients with ACS and heart failure. Obviously, elderly patients require a special approach to patient management, taking into account the complexity of clinical and anamnestic factors affecting the prognosis. AbstractAim. To study clinical and prognostic features of elderly patients with unstable angina pectoris undergoing conservative treatment depending on left ventricular ejection fraction (LVEF).Methods. 130 elderly patients, with mean age of 82 (77; 89) years, hospitalized for unstable angina with a GRACE score of less than 140 to a vascular center in Kemerovo were included in the study. During hospitalization, standard laboratory and instrumental studies were performed, except coronary angiography. The quality of life was assessed using the EQ-5D 3L questionnaire. After 12 months, patient compliance with treatment recommendations, primary and secondary endpoints, and quality of life were analyzed.Results. All patients were diagnosed with heart failure, 50 (38.5%) patients presented with LV EF less than 40% (the group I), 80 (61.5%) patients presented with LV EF more than 40% (the group II). The groups were comparable in gender, age, presence of multifocal of atherosclerotic disease, prevalence of aortic stenosis, arrhythmias and comorbidities. Women predominated in both groups, and arterial hypertension was noted in all patients. In the group I, a history of myocardial infarction, coronary revascularization, and NYHA FC III were more common (p0.05). Almost all patients were on triple neurohumoral blockade (beta-blockers, renin-angiotensin-aldosterone system inhibitors and mineralocorticoid receptor antagonists) for heart failure and dual antiplatelet therapy. One year later, 85.2% of patients in the group I and 90% of patients in the group II were taking all prescribed medication at low or medium therapeutic doses (without the need for drug titration). The overall mortality in the groups was 46% and 37.5%; cardiovascular deaths accounted for 32% and 30%, respectively (p>0.05). There were no differences in the frequency of endpoints (hospitalization, stroke, acute coronary syndrome, coronary revascularization) between the groups. The level of quality of life remained low in both groups.Conclusion. In patients over 75 years hospitalized for unstable angina, main clinical and anamnestic characteristics, annual prognosis and quality of life do not depend on LV EF, whereas the need for coronary revascularization during the 1 year remains high.
- 25 June 2023
- Published by NII KPSSZ in Complex Issues of Cardiovascular Diseases
- Vol. 12 (2) , 35-45
Open AccessCLINICAL AND PROGNOSTIC FEATURES OF ELDERLY PATIENTS WITH UNSTABLE ANGINA PECTORIS UNDERGOING CONSERVATIVE TREATMENT DEPENDING ON LEFT VENTRICULAR EJECTION FRACTION
Highlights High cardiovascular morbidity and mortality in the Russian Federation and in Kuzbass is mainly due to high number of elderly and senile patients; it simply reflects the current demographic situation in the country. Elderly and senile patients with acute coronary syndrome (ACS) account for 50% of hospitalized patients. In real clinical practice, a significant number of elderly patients with ACS receive conservative treatment, whereas the prognosis in this cohort is determined by the development of recurrent coronary events and the progression of heart failure. Due to small number of patients older than 75-80 years included in randomized clinical trials, there are certain gaps in the management of elderly patients with ACS and heart failure. Obviously, elderly patients require a special approach to patient management, taking into account the complexity of clinical and anamnestic factors affecting the prognosis. AbstractAim. To study clinical and prognostic features of elderly patients with unstable angina pectoris undergoing conservative treatment depending on left ventricular ejection fraction (LVEF).Methods. 130 elderly patients, with mean age of 82 (77; 89) years, hospitalized for unstable angina with a GRACE score of less than 140 to a vascular center in Kemerovo were included in the study. During hospitalization, standard laboratory and instrumental studies were performed, except coronary angiography. The quality of life was assessed using the EQ-5D 3L questionnaire. After 12 months, patient compliance with treatment recommendations, primary and secondary endpoints, and quality of life were analyzed.Results. All patients were diagnosed with heart failure, 50 (38.5%) patients presented with LV EF less than 40% (the group I), 80 (61.5%) patients presented with LV EF more than 40% (the group II). The groups were comparable in gender, age, presence of multifocal of atherosclerotic disease, prevalence of aortic stenosis, arrhythmias and comorbidities. Women predominated in both groups, and arterial hypertension was noted in all patients. In the group I, a history of myocardial infarction, coronary revascularization, and NYHA FC III were more common (p0.05). Almost all patients were on triple neurohumoral blockade (beta-blockers, renin-angiotensin-aldosterone system inhibitors and mineralocorticoid receptor antagonists) for heart failure and dual antiplatelet therapy. One year later, 85.2% of patients in the group I and 90% of patients in the group II were taking all prescribed medication at low or medium therapeutic doses (without the need for drug titration). The overall mortality in the groups was 46% and 37.5%; cardiovascular deaths accounted for 32% and 30%, respectively (p>0.05). There were no differences in the frequency of endpoints (hospitalization, stroke, acute coronary syndrome, coronary revascularization) between the groups. The level of quality of life remained low in both groups.Conclusion. In patients over 75 years hospitalized for unstable angina, main clinical and anamnestic characteristics, annual prognosis and quality of life do not depend on LV EF, whereas the need for coronary revascularization during the 1 year remains high.
- Open Access
- 1 January 2023
- Published by Altay State Medical University in Bulletin of Medical Science
- Vol. 30 (2) , 15-23
LONG-TERM EFFECTS OF OMEGA-3 POLYUNSATURATED FATTY ACIDS ON CORONARY HEART DISEASE IN PATIENTS WITH MULTIVESSEL STENOTIC CORONARY ARTERY ATHEROSCLEROSIS AND ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: POST-TRIAL ANALYSIS
Введение. Многочисленные исследования показали отчетливую связь между определенными диетическими жирами и смертностью. Однако данные о специфических пищевых жирах и смертности среди пациентов с кардиометаболическими заболеваниями остаются неоднозначными. Холестерин липопротеинов низкой плотности считается основной мишенью для профилактики и лечения атеросклеротических сердечно-сосудистых заболеваний. Вместе с тем у многих пациентов по-прежнему сохраняются остаточные сердечно-сосудистые риски, даже если холестерин липопротеинов низкой плотности достигает целевого уровня. Новые данные свидетельствуют о том, что повышенный уровень триглицеридов или холестерина липопротеинов, богатых триглицеридами, является одним из важных компонентов остаточного сердечно-сосудистого риска. Было показано, что жирные кислоты омега-3 являются одним из эффективных препаратов для снижения триглицеридов. Цель настоящего исследования состояла в том, чтобы оценить связь между длительным многолетним потреблением омега-3 жирных кислот и прогнозом пациентов с ишемической болезнью сердца на фоне многососудистого поражения коронарного русла после перенесенного инфаркта миокарда. Материалы и методы. Авторами проведено посттриальное наблюдение пациентов спустя 5 лет после окончания 12-месячного исследования эффективности и безопасности приема препаратов ω-3-ПНЖК в дозе 1000 мг/сут. на течение ишемической болезни сердца на фоне многососудистого поражения коронарного русла после перенесенного инфаркта миокарда. Ретроспективно все ранее участвовавшие в исследовании пациенты были разделены на три группы: 1 группа – пациенты, не получавшие ω-3-ПНЖК в течение основного исследования (информация получена о 111 пациентах), вторая группа – пациенты, получавшие ω-3-ПНЖК в течение исследования, но не принимавшие (или принимавшие эпизодически) препарат ω-3-ПНЖК в течение 5 лет после окончания исследования (получена информация о судьбе 61 такого пациента) и пациенты, принимавшие исследуемый препарат в ходе исследования и продолжившие его постоянный прием с перерывами не более двух недель, в течение 5 лет после окончания исследования (получена информация о 32 больных). Результаты и обсуждение. После прекращения приема препарата ω-3-ПНЖК в течение 5 лет полностью нивелируется его клиническая эффективность, зарегистрированная после 12 месяцев его постоянного приема, при этом достигнутый положительный эффект спустя 12 месяцев наблюдения при продолжении постоянного приема ω-3-ПНЖК на протяжении последующих пяти лет не только не ускользает, но и имеет кумулятивный характер (Р≤0,02-0,03). Нами констатирована важность именно длительного, желательно – пожизненного ω-3-ПНЖК в дозе 1000 мг в изучаемой когорте пациентов. Выводы. Результаты настоящего исследования свидетельствуют о том, что более низкая смертность от всех причин у пациентов с ишемической болезнью сердца на фоне многососудистого поражения коронарного русла после перенесенного инфаркта миокарда. может быть связана с потреблением ω-3-ПНЖК в дозе 1000 мг.
- 1 January 2023
- Published by Altay State Medical University in Bulletin of Medical Science
- Vol. 30 (2) , 15-23
Open AccessLONG-TERM EFFECTS OF OMEGA-3 POLYUNSATURATED FATTY ACIDS ON CORONARY HEART DISEASE IN PATIENTS WITH MULTIVESSEL STENOTIC CORONARY ARTERY ATHEROSCLEROSIS AND ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: POST-TRIAL ANALYSIS
Введение. Многочисленные исследования показали отчетливую связь между определенными диетическими жирами и смертностью. Однако данные о специфических пищевых жирах и смертности среди пациентов с кардиометаболическими заболеваниями остаются неоднозначными. Холестерин липопротеинов низкой плотности считается основной мишенью для профилактики и лечения атеросклеротических сердечно-сосудистых заболеваний. Вместе с тем у многих пациентов по-прежнему сохраняются остаточные сердечно-сосудистые риски, даже если холестерин липопротеинов низкой плотности достигает целевого уровня. Новые данные свидетельствуют о том, что повышенный уровень триглицеридов или холестерина липопротеинов, богатых триглицеридами, является одним из важных компонентов остаточного сердечно-сосудистого риска. Было показано, что жирные кислоты омега-3 являются одним из эффективных препаратов для снижения триглицеридов. Цель настоящего исследования состояла в том, чтобы оценить связь между длительным многолетним потреблением омега-3 жирных кислот и прогнозом пациентов с ишемической болезнью сердца на фоне многососудистого поражения коронарного русла после перенесенного инфаркта миокарда. Материалы и методы. Авторами проведено посттриальное наблюдение пациентов спустя 5 лет после окончания 12-месячного исследования эффективности и безопасности приема препаратов ω-3-ПНЖК в дозе 1000 мг/сут. на течение ишемической болезни сердца на фоне многососудистого поражения коронарного русла после перенесенного инфаркта миокарда. Ретроспективно все ранее участвовавшие в исследовании пациенты были разделены на три группы: 1 группа – пациенты, не получавшие ω-3-ПНЖК в течение основного исследования (информация получена о 111 пациентах), вторая группа – пациенты, получавшие ω-3-ПНЖК в течение исследования, но не принимавшие (или принимавшие эпизодически) препарат ω-3-ПНЖК в течение 5 лет после окончания исследования (получена информация о судьбе 61 такого пациента) и пациенты, принимавшие исследуемый препарат в ходе исследования и продолжившие его постоянный прием с перерывами не более двух недель, в течение 5 лет после окончания исследования (получена информация о 32 больных). Результаты и обсуждение. После прекращения приема препарата ω-3-ПНЖК в течение 5 лет полностью нивелируется его клиническая эффективность, зарегистрированная после 12 месяцев его постоянного приема, при этом достигнутый положительный эффект спустя 12 месяцев наблюдения при продолжении постоянного приема ω-3-ПНЖК на протяжении последующих пяти лет не только не ускользает, но и имеет кумулятивный характер (Р≤0,02-0,03). Нами констатирована важность именно длительного, желательно – пожизненного ω-3-ПНЖК в дозе 1000 мг в изучаемой когорте пациентов. Выводы. Результаты настоящего исследования свидетельствуют о том, что более низкая смертность от всех причин у пациентов с ишемической болезнью сердца на фоне многососудистого поражения коронарного русла после перенесенного инфаркта миокарда. может быть связана с потреблением ω-3-ПНЖК в дозе 1000 мг.